Picture of Terrascend logo

TSND — Terrascend News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapContrarian

Canada's TerrAscend Q3 revenue beats estimates driven by retail, wholesale growth in Pennsylvania

Canada's TerrAscend Q3 revenue beats estimates driven by retail, wholesale growth in Pennsylvania


Overview

  • Canada cannabis operator's Q3 revenue rose 4.8% yr/yr, beating analyst expectations

  • Adjusted EBITDA for Q3 rose slightly from prior year

  • Company renewed share buyback program, authorizing up to $10 mln in repurchases


Outlook

  • Company says it remains focused on driving top-tier adjusted EBITDA margins

  • TerrAscend is evaluating additional acquisition opportunities to support growth

  • Company plans to continue retail expansion in New Jersey


Result Drivers

  • PENNSYLVANIA GROWTH - Co said revenue growth was primarily driven by strong retail and wholesale growth in Pennsylvania

  • NEW JERSEY ACQUISITION - Co said acquisition of Aunt Mary's dispensary in New Jersey added revenue and was immediately accretive to EBITDA and cash flow

  • NEW JERSEY MARKET SHARE - Co said it maintained a leading position in New Jersey, gaining in sales and market share across key product categories


Company press release: ID:nGNX1B5z5p


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$68.20 mln

$66.87 mln (3 Analysts)

Q3 Gross Margin

52.30%

Q3 Net Income from Cont. Ops

-$5.50 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the drug retailers peer group is "buy"

  • Wall Street's median 12-month price target for Terrascend Corp is C$2.00, about 177.8% above its November 4 closing price of C$0.72


Reuters Recommended Reads

  • Nov 3 - Curaleaf Q3 revenue rises 11% on international segment growth

  • Nov 5 - Canada's Cronos Q3 revenue up 75% on cannabis flower demand in Israel, Germany

  • Nov 5 - Trulieve Cannabis Q3 revenue falls 20% yr/yr


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Terrascend

See all news